- Home
- ALT vs ELLO Comparison
ALT vs ELLO Comparison
Compare ALT & ELLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALT | ELLO |
|---|---|---|
| Founded | 1997 | 1987 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 382.0M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | ALT | ELLO |
|---|---|---|
| Price | $4.53 | $28.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 5.3M | 3.4K |
| Earning Date | 02-26-2026 | 12-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $20,000.00 | ★ $48,742,227.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 3.31 |
| 52 Week Low | $2.90 | $13.00 |
| 52 Week High | $7.73 | $30.34 |
Technical Indicators
Market Signals| Indicator | ALT | ELLO |
|---|---|---|
| Relative Strength Index (RSI) | 46.13 | 65.09 |
| Support Level | $4.47 | $27.58 |
| Resistance Level | $5.75 | $30.34 |
| Average True Range (ATR) | 0.44 | 0.60 |
| MACD | -0.10 | 0.11 |
| Stochastic Oscillator | 7.94 | 91.16 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About ELLO Ellomay Capital Ltd (Israel)
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions.